BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 12547727)

  • 21. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
    Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
    Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.
    Erdman SE; Rao VP; Poutahidis T; Rogers AB; Taylor CL; Jackson EA; Ge Z; Lee CW; Schauer DB; Wogan GN; Tannenbaum SR; Fox JG
    Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1027-32. PubMed ID: 19164562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells and intestinal homeostasis.
    Coombes JL; Robinson NJ; Maloy KJ; Uhlig HH; Powrie F
    Immunol Rev; 2005 Apr; 204():184-94. PubMed ID: 15790359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40.
    Tomczak MF; Erdman SE; Poutahidis T; Rogers AB; Holcombe H; Plank B; Fox JG; Horwitz BH
    J Immunol; 2003 Aug; 171(3):1484-92. PubMed ID: 12874241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells.
    Maloy KJ; Antonelli LR; Lefevre M; Powrie F
    Immunol Lett; 2005 Mar; 97(2):189-92. PubMed ID: 15752557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenicity of Helicobacter hepaticus infection in the lower bowel mucosa of 129/SvEv Rag2
    Ge Z; Feng Y; Sheh A; Muthupalani S; Gong G; Chawanthayatham S; Essigmann JM; Fox JG
    Int J Cancer; 2019 Aug; 145(4):1042-1054. PubMed ID: 30977112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.
    Morgan ME; Flierman R; van Duivenvoorde LM; Witteveen HJ; van Ewijk W; van Laar JM; de Vries RR; Toes RE
    Arthritis Rheum; 2005 Jul; 52(7):2212-21. PubMed ID: 15986351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease.
    Nishibori T; Tanabe Y; Su L; David M
    J Exp Med; 2004 Jan; 199(1):25-34. PubMed ID: 14699080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer.
    Wang C; Gong G; Sheh A; Muthupalani S; Bryant EM; Puglisi DA; Holcombe H; Conaway EA; Parry NAP; Bakthavatchalu V; Short SP; Williams CS; Wogan GN; Tannenbaum SR; Fox JG; Horwitz BH
    Mucosal Immunol; 2017 Nov; 10(6):1504-1517. PubMed ID: 28198364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes.
    Peng Y; Laouar Y; Li MO; Green EA; Flavell RA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4572-7. PubMed ID: 15070759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell transfer model of colitis: a great tool to assess the contribution of T cells in chronic intestinal inflammation.
    Eri R; McGuckin MA; Wadley R
    Methods Mol Biol; 2012; 844():261-75. PubMed ID: 22262449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colitis and colon cancer in WASP-deficient mice require helicobacter species.
    Nguyen DD; Muthupalani S; Goettel JA; Eston MA; Mobley M; Taylor NS; McCabe A; Marin R; Snapper SB; Fox JG
    Inflamm Bowel Dis; 2013 Sep; 19(10):2041-50. PubMed ID: 23820270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.
    Corazza N; Eichenberger S; Eugster HP; Mueller C
    J Exp Med; 1999 Nov; 190(10):1479-92. PubMed ID: 10562322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis.
    Maggio-Price L; Seamons A; Bielefeldt-Ohmann H; Zeng W; Brabb T; Ware C; Lei M; Hershberg RM
    Inflamm Bowel Dis; 2013 Jan; 19(1):174-84. PubMed ID: 22619032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice.
    Shin JY; Yoon IH; Lim JH; Shin JS; Nam HY; Kim YH; Cho HS; Hong SH; Kim JS; Lee WW; Park CG
    Cell Mol Immunol; 2015 Sep; 12(5):592-603. PubMed ID: 26211666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.
    Muthupalani S; Ge Z; Feng Y; Rickman B; Mobley M; McCabe A; Van Rooijen N; Fox JG
    Infect Immun; 2012 Dec; 80(12):4388-97. PubMed ID: 23027534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-23 drives innate and T cell-mediated intestinal inflammation.
    Hue S; Ahern P; Buonocore S; Kullberg MC; Cua DJ; McKenzie BS; Powrie F; Maloy KJ
    J Exp Med; 2006 Oct; 203(11):2473-83. PubMed ID: 17030949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
    Ghiringhelli F; Larmonier N; Schmitt E; Parcellier A; Cathelin D; Garrido C; Chauffert B; Solary E; Bonnotte B; Martin F
    Eur J Immunol; 2004 Feb; 34(2):336-44. PubMed ID: 14768038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice.
    Nagamine CM; Rogers AB; Fox JG; Schauer DB
    Int J Cancer; 2008 Feb; 122(4):832-8. PubMed ID: 17957786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.